Skip to main content
. 2015 Oct 19;17(9):735–741. doi: 10.1016/j.neo.2015.09.004

Figure 3.

Figure 3

Development of PDX tumors of different origin (lymphocytic tumor and adenocarcinoma) from the same patient tumor sample. (A) Breast PDX tumor model. First passage of breast PDX tumor (PCF #373342) grew as lymphocytic neoplasm in one mouse and as a poorly differentiated adenocarcinoma in another mouse after the initial SC transplantation of the same sample of a metastatic pleural effusion obtained from a breast cancer patient. (B) Pancreatic PDX tumor model. After initial SC transplantation of human primary pancreatic tumor (PCF #379419) into NSG mice, one mouse developed a B-cell PDX tumor, whereas another mouse developed an SC T-cell PDX tumor. The T-cell PDX tumor did not grow after retransplantation, whereas the B-cell PDX tumor progressed to a nonmetastatic pancreatic PDX tumor (adenocarcinoma) after retransplantation.